The chart below shows how TMO performed 10 days before and after its earnings report, based on data from the past quarters. Typically, TMO sees a +1.00% change in stock price 10 days leading up to the earnings, and a -0.72% change 10 days following the report. On the earnings day itself, the stock moves by -1.00%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Strong Financial Performance: Revenue for the quarter was $10.6 billion, reflecting strong financial performance.
Adjusted Operating Income and Margin: Adjusted operating income was $2.36 billion, with an adjusted operating margin of 22.3%.
Earnings Performance Highlight: The company achieved adjusted EPS of $5.28 per share, demonstrating robust earnings performance.
Free Cash Flow Increase: Year-to-date free cash flow increased by 22% compared to the same period last year, highlighting strong cash generation.
Adjusted EPS Guidance Increase: The company raised its adjusted EPS guidance for the year, now expecting a range of $21.35 to $22.07.
Negative
Revenue Stagnation Analysis: Q3 revenue was flat year-over-year, indicating a stagnation in growth.
Stagnant Organic Revenue Growth: Organic revenue growth was reported at 0%, reflecting a lack of expansion in the market.
Profitability Decline: Adjusted operating income decreased by 18%, highlighting a significant drop in profitability.
Operating Margin Decline: Adjusted operating margin was 13.5%, down 290 basis points compared to Q3 2023, indicating reduced efficiency.
Life Sciences Revenue Decline: The Life Sciences Solutions segment reported a 2% decline in revenue, showing challenges in that business area.
Thermo Fisher Scientific Inc. (TMO) Q3 2024 Earnings Call Transcript
TMO.N
1.53%